Background/aims The aim of this study was to evaluate the long-term corneal toxicity of topical chemotherapy with 1% 5-fluorouracil (5-FU) as a sole or adjuvant treatment of ocular surface squamous ...
Objective To evaluate efficacy and safety outcomes of the Xen 45 gel stent implant over 24 months of follow-up. Methods A retrospective analysis of prospectively collected data from the Fight Glaucoma ...
Visual loss in high myopia without pathologic myopia: a 5-year longitudinal study on the role of Choroidal Vascularity Index ...
Background The global burden of blindness and vision loss continues to increase, yet comprehensive analyses of underlying causes remain limited. This study estimated the global and regional burden of ...
1 School of Public Health, Medical College of Soochow University, Suzhou, China 2 School of Public Health, Sun Yat-Sen University, Guangzhou, China 3 Department of Ophthalmology, First Affiliated ...
Background Although health problems may persist beyond 4 weeks after SARS-CoV-2 infection, evidence on long-term ophthalmic ...
1 Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago—UIC, USA 2 Department of Ophthalmology and Visual Sciences, Paulista School of Medicine, ...
Prophylactic treatment of lattice degeneration with laser photocoagulation remains controversial. We evaluated whether prophylactic laser for lattice degeneration increases epiretinal membrane (ERM) ...
Purpose The cross-sectional and longitudinal associations between accelerated biological ageing and the risk of cataract and other blinding eye diseases (including glaucoma and age-related macular ...
Aims To compare 1-year and 2-year outcomes of eyes with persistent and non-persistent diabetic macular oedema (DME) treated with vascular endothelial growth factor (VEGF) inhibitors. Methods This was ...
Introduction Glaucoma is a lifelong condition often requiring surgical intervention. To allow us to inform patients’ expectations of surgery effectively, it is important to understand patients’ ...
Background Risk of non-arteritic anterior ischaemic optic neuropathy (NAION) following exposure to glucagon-like peptide-1 receptor agonists (GLP-1RAs) in people with type 2 diabetes and/or obesity ...